ACCESS PACK EXPO XPRESS ONLINE TODAY
ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.
LEARN MORE

FDA Clears First COVID-19 Breath Test

Move over painful swabs, now we have a breathalyzer that identifies compounds associated with SARS-CoV-2 infections.

A recent CNN article contained good news for people who prefer not to have swabs inserted deep into their nostrils. The FDA has granted emergency use authorization for a COVID-19 breath test. The diagnostic tool identifies chemical compounds associated with the virus in breath, and can be used in medical offices and mobile testing sites. The test is called the InspectIR Covid-19 Breathalyzer, and it detects five compounds associated with SARS-CoV-2 infections. A study on the device found that it was able to accurately identify 91% of positive samples, and virtually 100% of negative samples. A video with more information can be seen here. Finally, a breathalyzer I wouldn’t mind taking!

Access On-Demand Content Today
Discover innovative solutions for packaging and processing, automation, sustainability, e-commerce and more.
LEARN MORE
Access On-Demand Content Today
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts